Search research articles
Contact Us
Filters
Showing results (121-130 of 177) with videos related to
Page
of 18
Sort By:
European Heart Journal
|
June 16, 2007
External cardioversion of atrial fibrillation in patients with implanted pacemaker or cardioverter-defibrillator systems: a randomized comparison of monophasic and biphasic shock energy application
Johannes C Manegold, Carsten W Israel, Joachim R Ehrlich, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 22, 2006
Dose-finding study of fixed dose gemcitabine and escalating doses of ifosfamide given on days 1 and 8 in patients with advanced non-small cell lung cancer
S Baka, C Manegold, E Buchholz, et al.
Endoscopy
|
February 26, 2000
Thermoplastic stents: a new concept for endoluminal prosthesis
S Freudenberg, M Hartel, F Fernandez, et al.
Journal of Inherited Metabolic Disease
|
January 28, 2009
Aromatic L-amino acid decarboxylase deficiency: clinical features, drug therapy and follow-up
C Manegold, G F Hoffmann, I Degen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 9, 2006
Docetaxel and cisplatin as induction chemotherapy in patients with pathologically-proven stage IIIA N2 non-small cell lung cancer: a phase II study of the European organization for research and treatment of cancer (EORTC 08984)
B Biesma, C Manegold, H J M Smit, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 13, 2005
Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma
C Manegold, J Symanowski, U Gatzemeier, et al.
International Journal of Cancer
|
June 19, 2009
The dual EGFR/HER-2 tyrosine kinase inhibitor lapatinib sensitizes colon and gastric cancer cells to the irinotecan active metabolite SN-38
Melissa J LaBonte, Philipp C Manegold, Peter M Wilson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 11, 2017
Statistical controversies in clinical research: futility analyses in oncology-lessons on potential pitfalls from a randomized controlled trial
E Lesaffre, M J Edelman, N H Hanna, et al.
Bone and Mineral
|
August 1, 1993
Methylpentylaminopropylidenebisphosphonate (BM 21.0955): a new potent and safe bisphosphonate for the treatment of cancer-associated hypercalcemia
C Wüster, K H Schöter, D Thiébaud, et al.
Seminars in Oncology
|
April 16, 1998
Ifosfamide and gemcitabine: a phase II trial in advanced inoperable non-small cell lung cancer
U Gatzemeier, C Manegold, W Eberhard, et al.
Page
of 18
Search research articles
Search
Showing results (121-130 of 177) with videos related to
Sort By:
Page
of 18
European Heart Journal
|
June 16, 2007
External cardioversion of atrial fibrillation in patients with implanted pacemaker or cardioverter-defibrillator systems: a randomized comparison of monophasic and biphasic shock energy application
Johannes C Manegold, Carsten W Israel, Joachim R Ehrlich, et al.
Lung Cancer (Amsterdam, Netherlands)
|
June 22, 2006
Dose-finding study of fixed dose gemcitabine and escalating doses of ifosfamide given on days 1 and 8 in patients with advanced non-small cell lung cancer
S Baka, C Manegold, E Buchholz, et al.
Endoscopy
|
February 26, 2000
Thermoplastic stents: a new concept for endoluminal prosthesis
S Freudenberg, M Hartel, F Fernandez, et al.
Journal of Inherited Metabolic Disease
|
January 28, 2009
Aromatic L-amino acid decarboxylase deficiency: clinical features, drug therapy and follow-up
C Manegold, G F Hoffmann, I Degen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 9, 2006
Docetaxel and cisplatin as induction chemotherapy in patients with pathologically-proven stage IIIA N2 non-small cell lung cancer: a phase II study of the European organization for research and treatment of cancer (EORTC 08984)
B Biesma, C Manegold, H J M Smit, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 13, 2005
Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma
C Manegold, J Symanowski, U Gatzemeier, et al.
International Journal of Cancer
|
June 19, 2009
The dual EGFR/HER-2 tyrosine kinase inhibitor lapatinib sensitizes colon and gastric cancer cells to the irinotecan active metabolite SN-38
Melissa J LaBonte, Philipp C Manegold, Peter M Wilson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 11, 2017
Statistical controversies in clinical research: futility analyses in oncology-lessons on potential pitfalls from a randomized controlled trial
E Lesaffre, M J Edelman, N H Hanna, et al.
Bone and Mineral
|
August 1, 1993
Methylpentylaminopropylidenebisphosphonate (BM 21.0955): a new potent and safe bisphosphonate for the treatment of cancer-associated hypercalcemia
C Wüster, K H Schöter, D Thiébaud, et al.
Seminars in Oncology
|
April 16, 1998
Ifosfamide and gemcitabine: a phase II trial in advanced inoperable non-small cell lung cancer
U Gatzemeier, C Manegold, W Eberhard, et al.
Page
of 18